Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지

Loss of cholinergic innervations in rat hippocampus by intracerebral injection of C-terminal fragment of amyloid precursor protein

  • Han, Chang-Hoon (College of Veterinary Medicine, Cheju National University) ;
  • Lee, Young Jae (College of Veterinary Medicine, Cheju National University)
  • Accepted : 2008.09.01
  • Published : 2008.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

The neurotoxicity of C-terminal fragments of amyloid precusor protein (CT) is known to play some roles in Alzheimer's disease progression. In this study, we investigated the effects of the recombinant C-terminal 105 amino acid fragment of amyloid precusor protein (CT105) on cholinergic function using CT105-injected rat. To study the effects of CT105 on septohippocampal pathway, choline acetyltransferase (ChAT) positive neurons were examined in the medial septum and in the diagonal band after an injection of CT105 peptide into the lateral ventricle. Immunohistological analysis revealed that the number of ChAT-immunopositive cells decreased significantly in both medial septum and diagonal band. In addition, CT105 decreased ChAT-immunopositive cells in the hippocampal area, particulary in the dentate gyros. To study the effect of amyloid beta peptide ($A{\beta}$) and CT105 on the cholinergic system, each peptide was injected into the left lateral ventricle, and acetylcholine (ACh) levels were monitored in hippocampus. ACh level in the hippocampal area was reduced to 60% of control level in $A{\beta}$-treated group, and the level was reduced to 15% of control level in CT105-treated group, at one week after the injection. ACh level was further reduced to 35% of control in $A{\beta}$-treated group, whereas the level was slightly increased to 30% of control in CT105-treated group at 4 weeks after the injection. Taken together, the results in the present study suggest that CT105 impairs the septohippocampal pathway by reducing acetylcholine synthesis and release, which results in damage of learning and memory.

Keywords

References

  1. Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217, 408-414 https://doi.org/10.1126/science.7046051
  2. Baskin DS, Browning JL, Pirozzolo FJ, Korporaal S, Baskin JA, Appel SH. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol 1999, 56, 1121-1123 https://doi.org/10.1001/archneur.56.9.1121
  3. Beacb TG, Kuo YM, Spiegel K, Emmerling MR, Sue LI, Kokjobn K, Rober AE. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J Neuropathol Exp Neurol 2000, 59, 308-313 https://doi.org/10.1093/jnen/59.4.308
  4. Bird TD, Stranahan S, Sumi SM, Raskind M. Alzhemer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983, 14, 284-293 https://doi.org/10.1002/ana.410140306
  5. Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL,. Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M. Cholinetgic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci 2002, 22, 3234-3243 https://doi.org/10.1523/JNEUROSCI.22-08-03234.2002
  6. Bronfman FC, Moechars D, Van Leaven F. Acetylcholinesterase-posilivc fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol Dis 2000, 7, 152-168 https://doi.org/10.1006/nbdi.2000.0283
  7. Choi SH, Park CH, Koo JW, Seo JH, Kim HS, Jeoog SJ, Lee JH, Kim SS. Suh YH. Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice, FASEB J 2001, 15, 1816-1818 https://doi.org/10.1096/fj.00-0859fje
  8. Chong YH, Jung JM, Choi W, Park CW, Choi KS, Suh YH. Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci 1994, 54, 1259-1268 https://doi.org/10.1016/0024-3205(94)00853-1
  9. Chrobak JJ, Napier TC. Intraseptal administration of bicuculline produces working memory impairments in the rat. Behav Neural Biol 1991, 55, 247-254 https://doi.org/10.1016/0163-1047(91)80142-2
  10. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1983, 219, 1184-1190 https://doi.org/10.1126/science.6338589
  11. Cummings JL, Kaufer D. Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited. Neurology 1996, 47, 876-883 https://doi.org/10.1212/WNL.47.4.876
  12. Durkin TP. GABAergic mediation of indirect transsynaptic control over basal and spatial memory testing-induced activation of septo-hippocampal cholinergic activity in mice. Behav Brain Res 1992, 50, 155-165 https://doi.org/10.1016/S0166-4328(05)80297-9
  13. Emerich DF, Walsh TJ. Ganglioside AGF2 prevents the cognitive impainnents and cholinergic cell loss following intraventricular colchicine. Exp Neurol 1991, 112, 328-337 https://doi.org/10.1016/0014-4886(91)90135-Y
  14. Fadda F, Cocco S, Stancampiano R. Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats. Neuroreport 2000, 11, 2265-2269 https://doi.org/10.1097/00001756-200007140-00040
  15. Fraser SP, Suh YH, Djamgoz MBA. Ionic effects of the Alzheimer's disease $\beta -amyloid$ precursor protein and its metabolic fragments. Trends Neurosci 1997, 20, 67-72 https://doi.org/10.1016/S0166-2236(96)10079-5
  16. Gaykema RP, Luiten PG, Nyakas C, Traber J. Cortical projection patterns of the medial septumdiagonal band complex. J Comp Neurol 1990, 293, 103-124 https://doi.org/10.1002/cne.902930109
  17. Gaykema RP, Nyakas C, Horvath E, Hersb LB, Majtenyi C, Luiten PG. Cholinergic fiber aberrations in nucleus basalis lesioned rat and Alzheimer's disease. Neurobiol Aging 1992, 13, 441-448 https://doi.org/10.1016/0197-4580(92)90119-I
  18. Giacobini E. From molecular structure to Alzheimer therapy. Jpn J Pharmacol 1997, 74, 225-241 https://doi.org/10.1254/jjp.74.225
  19. Gilmor ML, Counts SE, Wley RG, Levey AI. Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions. J Neurochem 1998, 71, 2411-2420 https://doi.org/10.1046/j.1471-4159.1998.71062411.x
  20. Glenoer GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984, 120, 885-890 https://doi.org/10.1016/S0006-291X(84)80190-4
  21. Henke H, Lang W. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 1983, 267, 281-291 https://doi.org/10.1016/0006-8993(83)90880-6
  22. Ikonen S, Schmidt B, Rickkinen P Jr. Apamin improves spatial navigation in medial septal-Iesioned mice. Eur J Pharmacol 1998, 347, 13-21 https://doi.org/10.1016/S0014-2999(98)00075-2
  23. Itoh A, Nitta A, Nadai M, Nishimura K, Hirose M. Hasegawa T, Nabeshima T. Dysfunction of cholinergic and dopaminergic neuronal systems in betaamyloid protein-infused rats. J Neurochem 1996, 66, 1113-1117 https://doi.org/10.1046/j.1471-4159.1996.66031113.x
  24. Johnson DA, Zambon NJ, Gibbs RB. Selective lesion of cholinergic neurons in the medial septum by 192 IgG-saporin impairs learning in a delayed matching to position T-maze paradigm. Brain Res 2002, 943, 132-141 https://doi.org/10.1016/S0006-8993(02)02623-9
  25. Johnson DL, Kesner RP. The effects of lesions of the entorhinal cortex and the horizontal nucleus of the diagonal band of broca upon performance of a spatial location recognition task. Behav Brain Res 1994, 61, 1-8 https://doi.org/10.1016/0166-4328(94)90002-7
  26. Kar S, Issa AM, Seto D, Auld DS, Collier B. Quirion R. Amyloid beta-peptide inhibits high-affinity cholineuplake and acetylcholine release in rat hippocampal slices. J Neurochem 1998, 70, 2179-2187 https://doi.org/10.1046/j.1471-4159.1998.70052179.x
  27. Kasa P, Rakonczay Z. Gulya K. The cholinergic system in Alzheimer's disease. Prog Neurobiol 1997, 52, 511-535 https://doi.org/10.1016/S0301-0082(97)00028-2
  28. Kim HS, Lee JH, Suh YH. C-terminal fragment of Alzheimer's amyloid precursor protein inhibits sodium/ calcium exchanger activity in SK-N-SH cell. Neuroreport 1999, 10, 113-116 https://doi.org/10.1097/00001756-199901180-00022
  29. Kim HS, Park. CH, Cha SH, Lee JH, Lee S, Kim Y, Rah JC, Jeong SJ, Suh YH. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J 2000, 14, 1508-1517 https://doi.org/10.1096/fj.14.11.1508
  30. Kim JH, Rab JC. Fraser SP, Cbang KA, Djamgoz MBA, Suh YH. Carboxyl-terminal peptide of betaamyloid precursor protein blocks inositol 1,4,5- trisphosphate-sensitive $Ca^{2+}$ release in Xenopus laevis oocytes. J Biol Chem 2002, 277, 20256-20263 https://doi.org/10.1074/jbc.M108326200
  31. Kim SH, Sub YH. Neurotoxicity of a carboxylteminal fragment of the Alzheimer's amyloid precursor protein. J Neurochem 1996. 67, 1172-1182 https://doi.org/10.1046/j.1471-4159.1996.67031172.x
  32. Kitt CA, Hohmann C, Coyle JT, Price DL. Cholinergic innervation of mouse forebrain structures. J Comp Neurol 1994, 341, 117-129 https://doi.org/10.1002/cne.903410110
  33. Lang W, Henke H. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 1983, 267, 271-280 https://doi.org/10.1016/0006-8993(83)90879-X
  34. Lapchak PA, Jenden DJ, Herfti F. Compensatory elevation of acetylcholine synthesis in vivo by cholinergic neurons surviving panial lesions of the septohippocampal pathway. J Neurosci 1991, 11, 2821-2828 https://doi.org/10.1523/JNEUROSCI.11-09-02821.1991
  35. Lee JP, Chang KA, Kim HS, Kim SS. Jeoog SJ, Suh YH. APP carboxyl-teminal fragment without or with abeta domain equally induces cytotoxicity in differentiated PC12 cells and conical neurons. J Neurosci Res 2000, 60, 565-570 https://doi.org/10.1002/(SICI)1097-4547(20000515)60:4<565::AID-JNR16>3.0.CO;2-I
  36. Marston HM, West HL., Wilkinson LS. Everittt BJ, Robbins TW. Effects of excilotoxic lesions of the septum and vertical limb nucleus of the diagonal band of Broca on condilional visual discrimination: relationship between performance and choline acetyltransferase activity in the cingulate cortex. J Neurosci 1994, 14, 2009-2019 https://doi.org/10.1523/JNEUROSCI.14-04-02009.1994
  37. Maruyama K, Terakado K, Usami M, Yoshikawa K, Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor. Nature 1990, 347, 566-569 https://doi.org/10.1038/347566a0
  38. Matsumoto A, Fujiwara Y. Abnormal and deficient processing of beta-amyloid precursor protein in familial Alzheimer's disease Iymphoblastoid cells. Biochem Biophys Res Commun 1991, 175, 361-365 https://doi.org/10.1016/0006-291X(91)91572-T
  39. McKinney M, Coyle JT, Hedreen JC. Topographic analysis of the innervalion of the rat neorortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 1983, 217, 103-121 https://doi.org/10.1002/cne.902170109
  40. Minger SL, Esiri MM, McDonald B, Keene J, Carter J, Hope T, Francis PT. Cholinergic deficits contribute to behaviorai disturbance in patients with dementia. Neurology 2000, 55, 1460-1467 https://doi.org/10.1212/WNL.55.10.1460
  41. Nakamura S, Murayaml N, Noshita T, Annoura, H, Ohno T. Progressivc brain dyfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res 2001, 912, 128-136 https://doi.org/10.1016/S0006-8993(01)02704-4
  42. Nalbantoglu J, Tirado-Sanriago G, Lahsaini A, Poirier J , Goncalves O, Verge G, Momoli F, Welner SA, Massicotte G, Julien JP, Shapiro MLL. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 1997, 387, 500-505 https://doi.org/10.1038/387500a0
  43. Perry EK. The cholinergic hypothesis-ten years on. Br Med Bull. 1986, 42, 63-69 https://doi.org/10.1093/oxfordjournals.bmb.a072100
  44. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) 1984, 288, 961-964 https://doi.org/10.1136/bmj.288.6422.961
  45. Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljarvi L, Talasoiemi S, Ryynanen M, Riekkinen P Sr. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett 1995, 187, 79-82 https://doi.org/10.1016/0304-3940(95)11343-6
  46. Senut MC, Menecrey D, Lamour Y. Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of Broca to dorsal hippocampus, cingulate cortex and olfactory bulb: a combined wheatgerm aggIutinir-apohorseradish peroxidasegold immunohistochemical study. Neuroscience 1989, 30, 385-403 https://doi.org/10.1016/0306-4522(89)90260-1
  47. Song DK, Won MH, Jung JS, Lee JC, Kang TC, Suh HW, Huh SO, Paek SH, Kim YH, Kim SH, Suh YH. Behaviral and neuropathologic changes indueed by central injection of carboxyl-terminal fragment of beta-amyloid precursor protein in mice. J Neurochem 1998, 71, 875-878 https://doi.org/10.1046/j.1471-4159.1998.71020875.x
  48. Sub YH. An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease. J Neurochem 1997, 68, 1781-1791 https://doi.org/10.1046/j.1471-4159.1997.68051781.x
  49. Suh YH, Checler F. Amyloid precursor protein, presenilins, and alpna-synuclein: molecular pathogenesis and pharmacologicaI applications in Alzheimet's disease. Pharmacol Rev 2002, 54, 469-525 https://doi.org/10.1124/pr.54.3.469
  50. Wenk GL, Stoehr JD, Quintana. G, Mobley S, Wiley RG. Behaviorall, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 1994, 14, 5986-5995 https://doi.org/10.1523/JNEUROSCI.14-10-05986.1994
  51. Yamad. K, Taoaka T, Han D, Stnzaki K, Kameyama T, Nabeshima T. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 1999, 11, 83-90 https://doi.org/10.1046/j.1460-9568.1999.00408.x
  52. Yamada K, Tanaka T, Mamiya. T, Sbiotani T, Kamyama T, Nabeshima T. Improvement by nefiracctam of beta-amyloid-(1-42)-induced learning and memory impairments in rats. Br J Pharmacol 1999, 126, 235-244 https://doi.org/10.1038/sj.bjp.0702309
  53. Yamaguchi Y, Matsuno T, Kawashima S. Antiamnesic effects of azaindolizinone derivative ZSET845 on impaired learning and decrreased ChAT activity induced by amyloid-beta 25-35 in the rat. Brain Res 2002, 945, 259-265 https://doi.org/10.1016/S0006-8993(02)02816-0
  54. Yankner BA, Dawes LR, Fisher S, Villa.-Komaroff L, Osler-Cranite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989, 245, 417-420 https://doi.org/10.1126/science.2474201
  55. Zhao B, Sisodil SS, Kusilk JW. Altered processing of a mutant amyloid precursor protein in neuronal and endothelial cells. J Neurosci Res 1995, 40, 261-268 https://doi.org/10.1002/jnr.490400215